Leerink Partnrs Cuts Earnings Estimates for Encompass Health

Encompass Health Co. (NYSE:EHC) – Stock analysts at Leerink Partnrs decreased their Q2 2025 earnings per share (EPS) estimates for shares of Encompass Health in a note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $1.18 per share for the quarter, down from their prior forecast of $1.23. The consensus estimate for Encompass Health’s current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Encompass Health’s Q2 2026 earnings at $1.20 EPS, FY2027 earnings at $5.23 EPS and FY2028 earnings at $5.43 EPS.

Other equities research analysts have also recently issued reports about the company. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Barclays boosted their target price on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. Royal Bank of Canada restated an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a research report on Tuesday. KeyCorp boosted their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday. Finally, StockNews.com lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a report on Friday, February 7th. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Encompass Health currently has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Performance

Encompass Health stock opened at $98.04 on Thursday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health has a twelve month low of $72.53 and a twelve month high of $104.55. The company’s 50-day moving average price is $96.06 and its 200-day moving average price is $95.43. The company has a market cap of $9.88 billion, a PE ratio of 21.98, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. TD Private Client Wealth LLC grew its stake in Encompass Health by 2,870.0% in the 3rd quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock worth $709,000 after acquiring an additional 7,089 shares in the last quarter. Los Angeles Capital Management LLC boosted its holdings in shares of Encompass Health by 532.4% in the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after purchasing an additional 42,338 shares during the period. Pathstone Holdings LLC grew its stake in Encompass Health by 54.5% in the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after purchasing an additional 7,412 shares in the last quarter. Meeder Asset Management Inc. grew its stake in Encompass Health by 43.8% in the third quarter. Meeder Asset Management Inc. now owns 66,405 shares of the company’s stock worth $6,417,000 after purchasing an additional 20,242 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock valued at $161,781,000 after purchasing an additional 20,547 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.